(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on November 26, 2021)

Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.

Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.

For specific updates concerning China and related business advisory, please click here.

Please refresh the page to get the latest updates.

ASEAN coronavirus updates (Live updates by country)

Brunei

Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.   

• Brunei reported 70 new cases and one death on November 24, bringing the total to 14,771 cases and 97 deaths.
• Brunei recorded 71 new cases on November 23, taking the total to 14,701 cases amid 96 deaths.
• Brunei saw 39 new cases on November 22, bringing the total to 14,630 cases amid 96 deaths.

Cambodia

Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.  

• Cambodia saw 32 new cases and four deaths on November 25, bringing the tallies to 120,009 cases and 2,918 deaths.
• Cambodia reported 34 new cases and five deaths on November 24, taking the totals to 119,977 cases and 2,914 deaths.
• Cambodia recorded 39 new cases and four deaths on November 23, bringing the tallies to 119,943 cases and 2,909 deaths.

Indonesia

Indonesia has commenced vaccinations with just over nine million doses being given to front-line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 270 million. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population. 

• Indonesia reported 372 new cases and 16 deaths on November 25, bringing the totals to 4,254,815 cases and 143,782 deaths.
• Indonesia saw 451 new cases and 13 deaths on November 24, taking the tallies to 4,254,443 cases and 143,766 deaths.
• Indonesia recorded 394 new cases and nine deaths on November 23, bringing the totals to 4,253,992 cases and 143,753 deaths.

Laos

Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.  

• Laos reported 1,504 new cases and one death on November 24, bringing the totals to 67,322 cases and 143 deaths.
• Laos recorded 1,336 new cases and five deaths on November 23, taking the tallies to 65,818 cases and 142 deaths.
• Laos saw 1,323 new cases and four deaths on November 23, bringing the totals to 64,482 cases and 137 deaths.

Malaysia

Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens. 

• Malaysia recorded 6,144 new cases and 48 deaths on November 25, bringing the tallies to 2,608,979 cases and 30,195 deaths.
• Malaysia reported 5,755 new cases and 37 deaths on November 24, taking the totals to 2,602,835 cases and 30,147 deaths.
• Malaysia saw 5,594 new cases and 47 deaths on November 23, bringing the tallies to 2,597,080 cases and 30,110 deaths.

Myanmar

Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.   

• Myanmar reported 482 new cases and nine deaths on November 25, taking the totals to 520,213 cases and 19,058 deaths.
• Myanmar recorded 629 new cases and eight deaths on November 24, bringing the tallies to 519,731 cases and 19,049 deatyhs.
• Myanmar saw 631 new cases and seven deaths on November 23, taking the totals to 519,102 cases and 19,041 deaths.

Philippines

The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees. 

• The Philippines saw 975 new cases and 193 deaths on November 25, taking the totals to 2,829,618 cases and 47,875 deaths.
• The Philippines reported 890 new cases and 200 deaths on November 24, bringing the tallies to 2,828,660 cases and 47,682 deaths.
• The Philippines recorded 1,153 new cases and 195 deaths on November 23, taking the totals to 2,827,820 cases and 47,482 deaths.

Singapore

Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.     

• Singapore saw 2,079 new cases and six deaths on November 24, taking the totals to 257,510 cases and 678 deaths.
• Singapore recorded 1,782 new cases and five deaths on November 23, bringing the tallies to 255,431 cases and 672 deaths.
• Singapore reported 1,461 new cases and five deaths on November 22, taking the totals to 253,649 cases and 667 deaths.

Thailand

Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.   

• Thailand recorded 6,335 new cases and 37 deaths on November 25, bringing the tallies to 2,088,327 cases and 20,579 deaths.
• Thailand reported 5,857 new cases and 55 deaths on November 24, taking the totals to 2,081,992 cases and 20,542 deaths.
• Thailand saw 5,126 new cases and 53 deaths on November 23, bringing the tallies to 2,076,135 cases and 20,487 deaths.

Vietnam

Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.  

Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.

• Vietnam recorded 12,450 new cases and 164 deaths on November 25, bringing the totals to 1,168,228 cases and 24,407 deaths.
• Vietnam reported 11,811 new cases and 125 deaths on November 24, taking the tallies to 1,155,778 cases and 24,243 deaths.
• Vietnam saw 11,132 new cases and 167 deaths on November 23, bringing the totals to 1,143,967 cases and 24,118 deaths.

Other Asian countries and Regions

Afghanistan

Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either. 

• Afghanistan has 157,144 cases and 7,307 deaths as of November 25.
• As of November 24, Afghanistan has 157,032 cases and 7,307 deaths.
• Afghanistan has 157,015 cases and 7,305 deaths as of November 23.

Bangladesh

Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.     

• As of November 25, Bangladesh has 1,575,185 cases and 27,970 deaths.
• Bangladesh has 1,574,948 cases and 27,961 deaths as of November 24.
• As of November 23, Bangladesh has 1,574,636 cases and 27,958 deaths.

Bahrain

Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.  

• Bahrain has 277,510 cases and 1,394 deaths as of November 25.
• As of November 24, Bahrain has 277,481 cases and 1,394 deaths.
• Bahrain has 277,444 cases and 1,394 deaths as of November 23. 

China

For specific updates concerning China, please click here.

For a complete overview of China’s vaccine availability please go here.

• China saw 24 new cases on November 25, taking the total to 98,570.
• China reported 22 new cases on November 24, bringing the total to 98,546.
• China recorded 19 new cases on November 23, taking the total to 98,524.Top 

East Timor

East Timor is receiving assistance from the Gavi Institute.  

• East Timor has 19,820 cases and 122 deaths as of November 23.
• East Timor has 19,819 cases and 122 deaths as of November 20.
• As of November 19, East Timor has 19,816 cases and 122 deaths.

Hong Kong

Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.  

• Hong Kong has 12,418 cases and 213 deaths as of November 25.
• As of November 24, Hong Kong has 12,412 cases and 213 deaths.
• Hong Kong has 12,411 cases and 213 deaths as of November 23.

India

For a complete overview of India’s vaccine availability please go here.

• India has 34,546,926 cases and 466,980 deaths as of November 25.
• As of November 24, India has 34,541,349 cases and 466,584 deaths.
• Our new India-specific updates can be found here.

Iran

Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.   

• As of November 25, Iran has 6,097,672 cases and 129,376 deaths.
• Iran has 6,092,822 cases and 129,280 deaths as of November 24.
• Iran has 6,088,009 cases and 129,177 deaths as of November 23.

Iraq

Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021. 

• Iraq has 2,077,665 cases and 23,748 deaths as of November 25.
• As of November 24, Iraq has 2,076,922 cases and 23,725 deaths.
• Iraq has 2,076,146 cases and 23,712 deaths as of November 23.

Japan

Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021. 

• As of November 25, Japan has 1,726,705 cases and 18,352 deaths.
• Japan has 1,726,624 cases and 18,351 deaths as of November 24.
• Japan has 1,726,527 cases and 18,349 deaths as of November 23.

Jordan

Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021. 

• Jordan has 932,539 cases and 11,459 deaths as of November 25.
• As of November 24, Jordan has 928,256 cases and 11,429 deaths.
• Jordan has 923,722 cases and 11,403 deaths as of November 23.

Kazakhstan

Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.  

• Kazakhstan has 967,369 cases and 12,622 deaths as of November 25.
• Kazakhstan has 966,423 cases and 12,603 deaths as of November 24.
• As of November 23, Kazakhstan has 965,518 cases and 12,577 deaths.

Kuwait

All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.

• As of November 25, Kuwait has 413,224 cases and 2,465 deaths.
• Kuwait has 413,198 cases and 2,465 deaths as of November 24.
• Kuwait has 413,177 cases and 2,465 deaths as of November 23.

Kyrgyzstan

Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021. 

• Kyrgyzstan has 183,066 cases and 2,734 deaths as of November 25.
• As of November 24, Kyrgyzstan has 182,996 cases and 2,732 deaths.
• Kyrgyzstan has 182,953 cases and 2,729 deaths as of November 23.

Lebanon

Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.  

• Lebanon has 663,779 cases and 8,685 deaths as of November 25.
• As of November 24, Lebanon has 662,269 cases and 8,676 deaths.
• Lebanon has 660,442 cases and 8,666 deaths as of November 23 

The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.  

• The Maldives has 91,122 cases and 248 deaths as of November 25.
• The Maldives has 91,046 cases and 248 deaths as of November 24.
• As of November 23, the Maldives has 90,944 cases and 248 deaths.

Mongolia

Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021. 

• Mongolia has 379,544 cases and 1,976 deaths as of November 25.
• Mongolia has 378,833 cases and 1,969 deaths as of November 24.
• As of November 23, Mongolia has 378,199 cases and 1,958 deaths.

Nepal

Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.  

• Nepal has 820,285 cases and 11,516 deaths as of November 25.
• As of November 24, Nepal has 820,004 cases and 11,513 deaths.
• Nepal has 819,699 cases and 11,509 deaths as of November 23.

North Korea

North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.  

• North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.

Oman

Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).    

• As of November 25, Oman has 304,519 cases and 4,113 deaths.
• Oman has 304,514 cases and 4,113 deaths as of November 24.
• Oman has 304,509 cases and 4,113 deaths as of November 23.

Pakistan

Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021. 

• Pakistan has 1,283,223 cases and 28,690 deaths as of November 25.
• As of November 24, Pakistan has 1,282,860 cases and 28,677 deaths.
• Pakistan has 1,282,510 cases and 28,668 deaths as of November 23.

Palestine

Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.   

• As of November 25, Palestine has 429,123 cases and 4,521 deaths.
• Palestine has 428,857 cases and 4,520 deaths as of November 24.
• Palestine has 428,092 cases and 4,511 deaths as of November 22.Top 

Qatar

Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021. 

• Qatar has 242,673 cases and 611 deaths as of November 25.
• Qatar has 242,518 cases and 611 deaths as of November 24.
• As of November 23, Qatar has 242,375 cases and 611 deaths.

Russia

The complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.

• As of November 25, Russia has 9,468,189 cases and 269,057 deaths.
• Russia has 9,434,393 cases and 267,819 deaths as of November 24.
• Our new Russia-specific updates here.Top 

Saudi Arabia

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021. 

• As of November 25, Saudi Arabia has 549,618 cases and 8,829 deaths.
• Saudi Arabia has 549,590 cases and 8,828 deaths as of November 24.
• As of November 23, Saudi Arabia has 549,556 cases and 8,827 deaths.Top 

South Korea

South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021. 

• South Korea has 429,002 cases and 3,401 deaths as of November 25.
• South Korea has 425,065 cases and 3,363 deaths as of November 24.
• As of November 23, South Korea has 418,252 cases and 3,298 deaths.

Sri Lanka

Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.    

• Sri Lanka has 560,345 cases and 14,232 deaths as of November 25.
• As of November 24, Sri Lanka has 559,605 cases and 14,205 deaths.
• Sri Lanka has 558,860 cases and 14,182 deaths as of November 23.

Taiwan

Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.  

• Taiwan has 16,554 cases and 848 deaths as of November 25.
• As of November 24, Taiwan has 16,544 cases and 848 deaths.
• Taiwan has 16,539 cases and 848 deaths as of November 23.

Turkey

Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.   

• Turkey has 8,676,639 cases and 75,840 deaths as of November 25.
• As of November 24, Turkey has 8,652,172 cases and 75,618 deaths.
• Turkey has 8,624,580 cases and 75,443 deaths as of November 23.

United Arab Emirates

The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates.  The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.  

• The UAE has 741,720 cases and 2,145 deaths as of November 25.
• As of November 24, the UAE has 741,643 cases and 2,145 deaths.
• The UAE has 741,570 cases and 2,144 deaths as of November 23.

Uzbekistan

Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021. 

• Uzbekistan has 192,175 cases and 1,389 deaths as of November 25.
• As of November 24, Uzbekistan has 191,956 cases and 1,385 deaths.
• Uzbekistan has 191,750 cases and 1,382 deaths as of November 23.

Yemen

Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.   

• Yemen has 9,977 cases and 1,943 deaths as of November 25.
• As of November 24, Yemen has 9,972 cases and 1,942 deaths.
• Yemen has 9,967 cases and 1,942 deaths as of November 23.

By: https://www.aseanbriefing.com/

 November 26, 2021 Posted by ASEAN Briefing | Written byDezan Shira & Associates| Reading Time:13 minutes